Type 1 Diabetes in Childhood May Up Atopic Dermatitis Risk

This article originally appeared here.
Share this content:
Type 1 Diabetes in Childhood May Up Atopic Dermatitis Risk
Type 1 Diabetes in Childhood May Up Atopic Dermatitis Risk

FRIDAY, Sept. 18, 2015 (HealthDay News) -- Type 1 diabetes mellitus (T1DM) in childhood is associated with increased risk of atopic dermatitis (AD), according to a study published online Sept. 15 in the British Journal of Dermatology.

Chien-Heng Lin, from China Medical University Hospital in Taiwan, and colleagues examined the correlation between T1DM and AD in a population-based, retrospective cohort study. A total of 3,386 patients with T1DM newly diagnosed from 1998 to 2011 and 12,725 randomly selected controls without T1DM, frequency-matched by age, sex, and year of diagnosis, were identified from claims data of the National Health Insurance program of Taiwan.

The researchers found that the T1DM cohort had a 1.4-fold higher overall AD incidence compared with the nondiabetes cohort (3.31 versus 2.35 per 1,000 person-years). The overall risk of AD remained higher in the T1DM cohort after adjustment for potential risk factors (adjusted hazard ratio, 1.76). T1DM patients with more emergency room visits or hospitalizations had higher risk of subsequent AD (adjusted hazard ratios, 30.1 and 70.3, respectively) compared with the non-T1DM cohort.

"This nationwide, retrospective cohort study demonstrated that childhood T1DM may increase the risk of AD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »